Core Scientific, Inc.
CORZ
$22.79
-$0.16-0.70%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 162.61M | 89.81M | 67.24M | 70.79M | 84.95M |
| Total Other Revenue | 192.13M | 229.21M | 266.94M | 277.64M | 325.96M |
| Total Revenue | 354.74M | 319.02M | 334.18M | 348.43M | 410.91M |
| Cost of Revenue | 278.26M | 264.43M | 299.66M | 317.98M | 346.66M |
| Gross Profit | 76.48M | 54.59M | 34.52M | 30.46M | 64.25M |
| SG&A Expenses | 204.35M | 192.06M | 196.15M | 172.65M | 147.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 27.47M | 31.60M | -26.50M | -15.34M | 15.04M |
| Total Operating Expenses | 510.08M | 488.10M | 469.31M | 475.28M | 508.79M |
| Operating Income | -155.34M | -169.08M | -135.13M | -126.85M | -97.88M |
| Income Before Tax | -1.22B | -292.48M | -894.76M | -1.20B | -1.07B |
| Income Tax Expenses | 978.00K | 583.00K | 863.00K | 872.00K | 858.00K |
| Earnings from Continuing Operations | -1.22K | -293.06 | -895.62 | -1.20K | -1.07K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.22B | -293.06M | -895.62M | -1.20B | -1.07B |
| EBIT | -155.34M | -169.08M | -135.13M | -126.85M | -97.88M |
| EBITDA | -89.51M | -100.16M | -54.27M | -33.63M | 6.06M |
| EPS Basic | -1.78 | 0.71 | -0.89 | -1.60 | -5.26 |
| Normalized Basic EPS | -1.66 | -0.38 | -1.42 | -2.15 | -3.14 |
| EPS Diluted | -1.96 | 0.34 | -1.08 | -1.79 | -5.45 |
| Normalized Diluted EPS | -1.82 | -0.70 | -1.57 | -2.30 | -3.29 |
| Average Basic Shares Outstanding | 1.28B | 1.27B | 1.26B | 1.23B | 1.09B |
| Average Diluted Shares Outstanding | 1.42B | 1.46B | 1.31B | 1.28B | 1.14B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |